BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18226198)

  • 1. Effects of flavonoids on sphingolipid turnover in the toxin-damaged liver and liver cells.
    Babenko NA; Shakhova EG
    Lipids Health Dis; 2008 Jan; 7():1. PubMed ID: 18226198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Chamomilla recutita flavonoids on age-related liver sphingolipid turnover in rats.
    Babenko NA; Shakhova EG
    Exp Gerontol; 2006 Jan; 41(1):32-9. PubMed ID: 16183236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E prevents the age-dependent and palmitate-induced disturbances of sphingolipid turnover in liver cells.
    Babenko NA; Hassouneh LKh; Kharchenko VS; Garkavenko VV
    Age (Dordr); 2012 Aug; 34(4):905-15. PubMed ID: 21796379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
    Babenko NA; Kharchenko VS
    Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver.
    Babenko NA
    Med Sci Monit; 2005 May; 11(5):BR131-138. PubMed ID: 15874883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral sphingomyelinase-induced ceramide accumulation by oxidative stress during carbon tetrachloride intoxication.
    Ichi I; Kamikawa C; Nakagawa T; Kobayashi K; Kataoka R; Nagata E; Kitamura Y; Nakazaki C; Matsura T; Kojo S
    Toxicology; 2009 Jun; 261(1-2):33-40. PubMed ID: 19394401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: In vitro and in vivo studies.
    Ai G; Liu Q; Hua W; Huang Z; Wang D
    J Ethnopharmacol; 2013 Apr; 146(3):794-802. PubMed ID: 23422335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging.
    Lightle SA; Oakley JI; Nikolova-Karakashian MN
    Mech Ageing Dev; 2000 Dec; 120(1-3):111-25. PubMed ID: 11087909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in sphingolipid catabolic enzyme activity during aging.
    Sacket SJ; Chung HY; Okajima F; Im DS
    Acta Pharmacol Sin; 2009 Oct; 30(10):1454-61. PubMed ID: 19749786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
    Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
    J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term food restriction prevents aging-associated sphingolipid turnover dysregulation in the brain.
    Babenko NA; Shakhova EG
    Arch Gerontol Geriatr; 2014; 58(3):420-6. PubMed ID: 24439723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
    Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
    Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis].
    Serebrov VIu; Kuz'menko DI; Burov PG; Sapugol'tseva OB
    Biomed Khim; 2010; 56(2):283-9. PubMed ID: 21341516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
    Zager RA; Burkhart KM; Johnson A
    J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubus sanctus protects against carbon tetrachloride-induced toxicity in rat isolated hepatocytes: isolation and characterization of its galloylated flavonoids.
    Badr AM; El-Demerdash E; Khalifa AE; Ghoneim AI; Ayoub NA; Abdel-Naim AB
    J Pharm Pharmacol; 2009 Nov; 61(11):1511-20. PubMed ID: 19903377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
    Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
    Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of the total flavonoids from Apocynum venetum L. on carbon tetrachloride-induced hepatotoxicity in vitro and in vivo.
    Zhang W; Dong Z; Chang X; Zhang C; Rong G; Gao X; Zeng Z; Wang C; Chen Y; Rong Y; Qu J; Liu Z; Lu Y
    J Physiol Biochem; 2018 May; 74(2):301-312. PubMed ID: 29541948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
    Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
    Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.